The use of puberty blockers may result in vision loss. The FDA issues a warning about idiopathic intracranial hypertension, also known as pseudotumor cerebri in children.
Gonadotropin-releasing hormone (GnRH) agonists, often known as puberty blockers, now include a warning from the U.S. Food and Drug Administration that the drugs may result in a range of symptoms in children, including headaches, pressure building around the brain, and vision loss.
The agency issued a warning on July ...